USD 8.525
↓ -0.325 (-3.67%)
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| ENVX | -3.7 | -4.2 | -28.5 | -20.0 | -8.7 | -26.6 | -73.9 | -32.1 | -32.1 | -32.1 |
| S&P 500 | -1.4 | -1.9 | 0.8 | 5.8 | 10.5 | 30.2 | 25.2 | 87.9 | 187.2 | 33100.6 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | ENVX |
| name | Enovix Corporation |
| price | 8.525 |
| changes percentage | -3.6709 |
| change | -0.325 |
| day low | 8.495 |
| day high | 8.83 |
| year high | 18.68 |
| year low | 5.7 |
| market cap | 1606058850 |
| price avg 50 | 9.9742 |
| price avg 200 | 10.447175 |
| exchange | NASDAQ |
| volume | 3623940 |
| avg volume | 5981243 |
| open | 8.81 |
| previous close | 8.85 |
| eps | -1.45 |
| pe | -5.88 |
| earnings announcement | 2025-02-18T05:00:00.000+0000 |
| shares outstanding | 188394000 |
| timestamp | 2024-11-15 20:47:10 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001828318 | |||
| revenue | 263000 | 6202000 | -95.76 |
| gross profit | -43029000 | -17037000 | -152.56 |
| gross profit ratio | -163.61 | -2.75 | -5855.86 |
| research and development expenses | 53810000 | 58051000 | -7.31 |
| operating expenses | 115017000 | 110021000 | 4.54 |
| interest income | 9942000 | 5231000 | 90.06 |
| interest expense | -2827000 | 5231000 | -154.04 |
| ebitda | -165478000 | -189345000 | 12.61 |
| ebitdaratio | -629.19 | -30.53 | -1960.93 |
| operating income | -165478000 | -131979000 | -25.38 |
| operating income ratio | -629.19 | -21.28 | -2856.73 |
| net income | -154094000 | 99304000 | -255.17 |
| net income ratio | -585.91 | 16.01 | -3759.27 |
| eps | -0.98 | 0.65 | -250.77 |
Revenue Growth: revenue decreased to 0 million in 2023 from 6 million in 2022 representing a change of -95.76%. This indicates a sales shrinking, which is a negative sign for the company.
Gross Profit: Gross Profit decreased to -43 million in 2023 from -17 million in 2022 representing a change of -152.56%. This indicates a sales profitability decline, which is a negative sign for the company.
Research and Development (R&D) Expenses: R&D Expenses decreased to 54 million in 2023 from 58 million in 2022 representing a change of -7.31%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
Operating Expenses: Operating Expenses increased to 115 million in 2023 from 110 million in 2022 representing a change of 4.54%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -165 million in 2023 from -189 million in 2022 representing a change of 12.61%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Net Income: Net income decreased to -154 million in 2023 from 99 million in 2022 representing a change of -255.17%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to -0.98 in 2023 from -0.98 in 2022 representing a change of -250.77%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
Operating Income: Operating income increased to -165 million in 2023 from -132 million in 2022 representing a change of -25.38%. The increase in operating income indicates better operational performance and increased profitability.
| 2024Q2 | 2024Q1 | Q/Q change % | |
|---|---|---|---|
| 0001828318 | |||
| revenue | 3768000 | 5272000 | -28.53 |
| gross profit | -655000 | -1800000 | 63.61 |
| gross profit ratio | -0.17 | -0.34 | 49.09 |
| research and development expenses | 29065000 | 48788000 | -40.43 |
| operating expenses | 49949000 | 68336000 | -26.91 |
| interest income | 3326000 | 3560000 | -6.57 |
| interest expense | 1691000 | 1659000 | 1.93 |
| ebitda | -41093000 | -41136000 | 0.10 |
| ebitdaratio | -10.91 | -7.8 | -39.77 |
| operating income | -88750000 | -70136000 | -26.54 |
| operating income ratio | -23.55 | -13.3 | -77.05 |
| net income | -115872000 | -46368000 | -149.90 |
| net income ratio | -30.75 | -8.8 | -249.64 |
| eps | -0.67 | -0.28 | -139.29 |
Revenue Growth: revenue decreased to 4 million in 2024Q2 from 5 million in 2024Q1 representing a change of -28.53%. This indicates a sales shrinking, which is a negative sign for the company.
Research and Development (R&D) Expenses: R&D Expenses decreased to 29 million in 2024Q2 from 49 million in 2024Q1 representing a change of -40.43%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -41 million in 2024Q2 from -41 million in 2024Q1 representing a change of 0.1%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Net Income: Net income decreased to -116 million in 2024Q2 from -46 million in 2024Q1 representing a change of -149.9%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to -0.67 in 2024Q2 from -0.67 in 2024Q1 representing a change of -139.29%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
Gross Profit: Gross Profit increased to -1 million in 2024Q2 from -2 million in 2024Q1 representing a change of 63.61%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses decreased to 50 million in 2024Q2 from 68 million in 2024Q1 representing a change of -26.91%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
Operating Income: Operating income increased to -89 million in 2024Q2 from -70 million in 2024Q1 representing a change of -26.54%. The increase in operating income indicates better operational performance and increased profitability.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001828318 | |||
| total assets | 564304000 | 440586000 | 28.08 |
| total liabilities | 303201000 | 84159000 | 260.27 |
| total equity | 261103000 | 356427000 | -26.74 |
| cash and cash equivalents | 233121000 | 322851000 | -27.79 |
| short term investments | 73694000 | 0 | NaN |
| long term investments | 2001999 | 0 | NaN |
| total current assets | 323177000 | 329648000 | -1.96 |
| total non current assets | 241127000 | 110938000 | 117.35 |
| total current liabilities | 61018000 | 23029000 | 164.96 |
| total non current liabilities | 242183000 | 61130000 | 296.18 |
| common stock | 17000 | 15000 | 13.33 |
| retained earnings | -598845000 | -384774000 | -55.64 |
| total debt | 190610000 | 8234000 | 2214.91 |
Total Assets: Total Assets increased to 564 million in 2023 from 441 million in 2022 representing a change of 28.08%. Suggesting a growth in asset holdings.
Short Term Investments: Short Term Investments increased to 74 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in short-term investment holdings.
Common Stock: Common Stock increased to 0 in 2023 from 0 in 2022 representing a change of 13.33%. This indicates an increase in ownership interest.
Total Liabilities: Total Liabilities increased to 303 million in 2023 from 84 million in 2022 representing a change of 260.27%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 261 million in 2023 from 356 million in 2022 representing a change of -26.74%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 233 million in 2023 from 323 million in 2022 representing a change of -27.79%. This indicates a decrease in available liquid assets.
Total Current Assets: Total Current Assets decreased to 323 million in 2023 from 330 million in 2022 representing a change of -1.96%. This indicates a worsen liquidity position.
Total Current Liabilities: Total Current Liabilities increased to 61 million in 2023 from 23 million in 2022 representing a change of 164.96%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -599 million in 2023 from -385 million in 2022 representing a change of -55.64%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 191 million in 2023 from 8 million in 2022 representing a change of 2214.91%. This indicates an increase in overall debt burden.
| 2024Q2 | 2024Q1 | Q/Q change % | |
|---|---|---|---|
| 0001828318 | |||
| total assets | 488988000 | 508903000 | -3.91 |
| total liabilities | 315925000 | 276798000 | 14.14 |
| total equity | 173063000 | 232105000 | -25.44 |
| cash and cash equivalents | 235103000 | 222150000 | 5.83 |
| short term investments | 14826000 | 40243000 | -63.16 |
| long term investments | 1872000 | 1924000 | -2.70 |
| total current assets | 269949000 | 278008000 | -2.90 |
| total non current assets | 219039000 | 230895000 | -5.13 |
| total current liabilities | 67903000 | 56884000 | 19.37 |
| total non current liabilities | 248022000 | 219914000 | 12.78 |
| common stock | 18000 | 17000 | 5.88 |
| retained earnings | -761085000 | -645213000 | -17.96 |
| total debt | 193671000 | 191576000 | 1.09 |
Total Assets: Total Assets decreased to 489 million in 2024Q2 from 509 million in 2024Q1 representing a change of -3.91%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 316 million in 2024Q2 from 277 million in 2024Q1 representing a change of 14.14%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 173 million in 2024Q2 from 232 million in 2024Q1 representing a change of -25.44%. This indicates a decrease in shareholders' equity.
Short Term Investments: Short Term Investments decreased to 15 million in 2024Q2 from 40 million in 2024Q1 representing a change of -63.16%. This indicates a decrease in short-term investment holdings.
Total Current Assets: Total Current Assets decreased to 270 million in 2024Q2 from 278 million in 2024Q1 representing a change of -2.9%. This indicates a worsen liquidity position.
Total Current Liabilities: Total Current Liabilities increased to 68 million in 2024Q2 from 57 million in 2024Q1 representing a change of 19.37%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -761 million in 2024Q2 from -645 million in 2024Q1 representing a change of -17.96%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 194 million in 2024Q2 from 192 million in 2024Q1 representing a change of 1.09%. This indicates an increase in overall debt burden.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 235 million in 2024Q2 from 222 million in 2024Q1 representing a change of 5.83%. This indicates an increase in available liquid assets.
Common Stock: Common Stock increased to 0 in 2024Q2 from 0 in 2024Q1 representing a change of 5.88%. This indicates an increase in ownership interest.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001828318 | |||
| net change in cash | -52034000 | -62442000 | 16.67 |
| operating cash flow | -77408000 | -82740000 | 6.44 |
| free cash flow | -110387000 | -118952000 | 7.20 |
| capital expenditure | -32979000 | -36212000 | 8.93 |
| depreciation and amortization | 11002000 | 7972000 | 38.01 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 57832000 | 30367000 | 90.44 |
| accounts payables | 4338000 | 2272000 | 90.93 |
| inventory | 418000 | -634000 | 165.93 |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -32979000 | -36212000 | 8.93 |
| net cash used for investing activites | -132015000 | -36212000 | -264.56 |
| debt repayment | 0 | 0 | NaN |
| common stock issued | 14278000 | 52828000 | -72.97 |
| common stock repurchased | -26000 | -10000 | -160.00 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 159585000 | 56510000 | 182.40 |
| cash at end of period | 270942000 | 322976000 | -16.11 |
| accounts receivables | 169000 | -170000 | 199.41 |
| cash at beginning of period | 322976000 | 385418000 | -16.20 |
Net Change in Cash: Net Change in Cash increased to -52 million in 2023 from -62 million in 2022 representing a change of 16.67%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to -77 million in 2023 from -83 million in 2022 representing a change of 6.44%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to -110 million in 2023 from -119 million in 2022 representing a change of 7.2%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure increased to -33 million in 2023 from -36 million in 2022 representing a change of 8.93%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Stock-Based Compensation: Stock-Based Compensation increased to 58 million in 2023 from 30 million in 2022 representing a change of 90.44%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 4 million in 2023 from 2 million in 2022 representing a change of 90.93%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to 0 in 2023 from 0 million in 2022 representing a change of 199.41%. This suggests that the company is less capable of collecting payments from its customers.
| 2024Q2 | 2024Q1 | Q/Q change % | |
|---|---|---|---|
| 0001828318 | |||
| operating cash flow | -26949000 | -35044000 | 23.10 |
| free cash flow | -52158000 | -50132000 | -4.04 |
| capital expenditure | -25209000 | -15088000 | -67.08 |
| depreciation and amortization | 5943000 | 24974000 | -76.20 |
| deferred income tax | -4586000 | -222000 | -1965.77 |
| stock based compensation | 19037000 | 12760000 | 49.19 |
| accounts receivables | 164000 | 505000 | -67.52 |
| accounts payables | -969000 | -7281000 | 86.69 |
| inventory | -2973000 | 2202000 | -235.01 |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -25209000 | -15088000 | -67.08 |
| net cash used for investing activites | 406000 | 19106000 | -97.88 |
| debt repayment | 0 | 0 | NaN |
| common stock issued | 38046000 | 5852000 | 550.14 |
| common stock repurchased | -1000 | -2222000 | 99.95 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 39651000 | 5430000 | 630.22 |
| net change in cash | 12901000 | -11049000 | 216.76 |
| cash at end of period | 236975000 | 224074000 | 5.76 |
| cash at beginning of period | 224074000 | 235123000 | -4.70 |
Net Change in Cash: Net Change in Cash increased to 13 million in 2024Q2 from -11 million in 2024Q1 representing a change of 216.76%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to -27 million in 2024Q2 from -35 million in 2024Q1 representing a change of 23.1%. This indicates that the company generated more cash from its core business operations.
Capital Expenditure: Capital Expenditure decreased to -25 million in 2024Q2 from -15 million in 2024Q1 representing a change of -67.08%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Accounts Payables: The absolute value of Accounts Payables decreased to 1 million in 2024Q2 from 7 million in 2024Q1 representing a change of 86.69%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables decreased to 0 million in 2024Q2 from 1 million in 2024Q1 representing a change of -67.52%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Free Cash Flow: Free Cash Flow decreased to -52 million in 2024Q2 from -50 million in 2024Q1 representing a change of -4.04%. This indicates a decrease in cash generated after accounting for capital expenditures.
Stock-Based Compensation: Stock-Based Compensation increased to 19 million in 2024Q2 from 13 million in 2024Q1 representing a change of 49.19%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2023-01-01 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 0.0 | 0.04 | -95.88 |
| net income per share | -0.98 | 0.65 | -250.60 |
| operating cash flow per share | -0.49 | -0.54 | 9.20 |
| free cash flow per share | -0.7 | -0.78 | 9.93 |
| cash per share | 1.95 | 2.11 | -7.77 |
| book value per share | 1.66 | 2.33 | -28.90 |
| tangible book value per share | 1.31 | 2.33 | -43.68 |
| shareholders equity per share | 1.64 | 2.33 | -29.71 |
| interest debt per share | 1.19 | 0.09 | 1253.52 |
| market cap | 1972640407.76 | 1902303490.28 | 3.70 |
| enterprise value | 1930129407.76 | 1587686490.28 | 21.57 |
| pe ratio | -12.8 | 19.16 | -166.83 |
| price to sales ratio | 7500.53 | 306.72 | 2345.37 |
| pocfratio | -25.48 | -22.99 | -10.84 |
| pfcf ratio | -17.87 | -15.99 | -11.74 |
| pb ratio | 7.64 | 5.34 | 43.18 |
| ptb ratio | 7.64 | 5.34 | 43.18 |
| ev to sales | 7338.9 | 256.0 | 2766.80 |
| enterprise value over ebitda | -11.66 | -8.39 | -39.10 |
| ev to operating cash flow | -24.93 | -19.19 | -29.94 |
| ev to free cash flow | -17.49 | -13.35 | -31.00 |
| earnings yield | -0.08 | 0.05 | -249.64 |
| free cash flow yield | -0.06 | -0.06 | 10.51 |
| debt to equity | 0.74 | 0.02 | 3096.23 |
| debt to assets | 0.34 | 0.02 | 1707.39 |
| net debt to ebitda | 0.26 | 1.66 | -84.54 |
| current ratio | 5.3 | 14.31 | -63.00 |
| interest coverage | 58.53 | -25.23 | 332.00 |
| income quality | 0.5 | 1.6 | -68.66 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 204.6 | 9.36 | 2085.90 |
| intangibles to total assets | 0.1 | 0 | NaN |
| capex to operating cash flow | -0.43 | -0.44 | 2.65 |
| capex to revenue | 125.4 | 5.84 | 2047.64 |
| capex to depreciation | 3.0 | 4.54 | -34.01 |
| stock based compensation to revenue | 219.89 | 4.9 | 4390.99 |
| graham number | 6.0 | 5.84 | 2.89 |
| roic | -0.37 | 0.7 | -152.96 |
| return on tangible assets | -0.3 | 0.23 | -234.04 |
| graham net net | 0.06 | 1.56 | -96.02 |
| working capital | 262159000 | 306619000 | -14.50 |
| tangible asset value | 206837000 | 356427000 | -41.97 |
| net current asset value | 19976000 | 245489000 | -91.86 |
| invested capital | 498186000 | 416620000 | 19.58 |
| average receivables | 1296500 | 85000 | 1425.29 |
| average payables | 14164000 | 5110500 | 177.15 |
| average inventory | 4685500 | 317000 | 1378.08 |
| days sales outstanding | 3362.72 | 10.0 | 33510.93 |
| days payables outstanding | 179.17 | 111.15 | 61.19 |
| days of inventory on hand | 73.66 | 9.96 | 639.75 |
| receivables turnover | 0.11 | 36.48 | -99.70 |
| payables turnover | 2.04 | 3.28 | -37.96 |
| inventory turnover | 4.96 | 36.65 | -86.48 |
| roe | -0.6 | 0.28 | -314.25 |
| capex per share | 0.21 | 0.24 | -11.61 |
ROE: Return on Equity (ROE) decreased to -0.60 on 2023-12-31 from 0.28 on 2023-01-01, representing a change of -314.25%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -12.80 on 2023-12-31 from 19.16 on 2023-01-01, representing a change of -166.83%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 5.30 on 2023-12-31 from 14.31 on 2023-01-01, representing a change of -63.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.74 on 2023-12-31 from 0.02 on 2023-01-01, representing a change of 3096.23%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-06-30 Q2 | 2024-03-31 Q1 | Q/Q change % | |
|---|---|---|---|
| ENVX | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 0.02 | 0.03 | -30.29 |
| net income per share | -0.67 | -0.28 | -143.73 |
| operating cash flow per share | -0.16 | -0.21 | 25.00 |
| free cash flow per share | -0.3 | -0.3 | -1.47 |
| cash per share | 1.45 | 1.56 | -7.10 |
| book value per share | 1.0 | 1.38 | -27.28 |
| tangible book value per share | 0.71 | 1.07 | -33.83 |
| shareholders equity per share | 0.99 | 1.36 | -27.55 |
| interest debt per share | 1.13 | 1.15 | -1.39 |
| market cap | 2603227497.2 | 1330026301.38 | 95.73 |
| enterprise value | 2561795497.2 | 1299452301.38 | 97.14 |
| pe ratio | -5.62 | -7.17 | 21.68 |
| price to sales ratio | 690.88 | 252.28 | 173.85 |
| pocfratio | -96.6 | -37.95 | -154.52 |
| pfcf ratio | -49.91 | -26.53 | -88.12 |
| pb ratio | 15.29 | 5.8 | 163.49 |
| ptb ratio | 15.29 | 5.8 | 163.49 |
| ev to sales | 679.88 | 246.48 | 175.83 |
| enterprise value over ebitda | -62.34 | -31.59 | -97.35 |
| ev to operating cash flow | -95.06 | -37.08 | -156.36 |
| ev to free cash flow | -49.12 | -25.92 | -89.49 |
| earnings yield | -0.04 | -0.03 | -27.68 |
| free cash flow yield | -0.02 | -0.04 | 46.84 |
| debt to equity | 1.14 | 0.84 | 36.10 |
| debt to assets | 0.4 | 0.38 | 5.21 |
| net debt to ebitda | 1.01 | 0.74 | 35.66 |
| current ratio | 3.98 | 4.89 | -18.66 |
| interest coverage | -52.48 | -42.28 | -24.15 |
| income quality | 0.23 | 0.75 | -69.16 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 1.18 | -100.00 |
| research and ddevelopement to revenue | 7.71 | 9.25 | -16.65 |
| intangibles to total assets | 0.1 | 0.1 | 1.70 |
| capex to operating cash flow | -0.94 | -0.43 | -117.27 |
| capex to revenue | 6.69 | 2.86 | 133.77 |
| capex to depreciation | 4.24 | 0.6 | 602.11 |
| stock based compensation to revenue | 5.05 | 2.42 | 108.74 |
| graham number | 3.87 | 2.91 | 32.88 |
| roic | -0.23 | -0.17 | -41.20 |
| return on tangible assets | -0.26 | -0.1 | -160.58 |
| graham net net | -0.35 | -0.06 | -501.16 |
| working capital | 202046000 | 221124000 | -8.63 |
| tangible asset value | 122072000 | 179925000 | -32.15 |
| net current asset value | -45976000 | 1210000 | -3899.67 |
| invested capital | 418394000 | 447319000 | -6.47 |
| average receivables | 1770000 | 2147500 | -17.58 |
| average payables | 19354000 | 20264000 | -4.49 |
| average inventory | 8022000 | 7636500 | 5.05 |
| days sales outstanding | 39.84 | 31.96 | 24.67 |
| days payables outstanding | 395.39 | 245.32 | 61.17 |
| days of inventory on hand | 193.47 | 83.18 | 132.60 |
| receivables turnover | 2.26 | 2.82 | -19.79 |
| payables turnover | 0.23 | 0.37 | -37.95 |
| inventory turnover | 0.47 | 1.08 | -57.01 |
| roe | -0.68 | -0.2 | -236.42 |
| capex per share | 0.15 | 0.09 | 62.96 |
ROE: Return on Equity (ROE) decreased to -0.68 on 2024-06-30 Q2 from -0.20 on 2024-03-31 Q1, representing a change of -236.42%. Suggesting that the company has not been generating high returns for its shareholders.
Current Ratio: Current Ratio decreased to 3.98 on 2024-06-30 Q2 from 4.89 on 2024-03-31 Q1, representing a change of -18.66%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to -5.62 on 2024-06-30 Q2 from -7.17 on 2024-03-31 Q1, representing a change of 21.68%. Indicating an increase in the relative valuation of the company's stock.
Debt-to-Equity Ratio:
Negative Sentiment: Discounted Cash Flow value is 0.27 which is lower than current price 8.53, indicates the company may be overvalued.
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Neutral
Publish Date: 2024-11-06 08:30:00
FREMONT, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today its participation in the following upcoming investor events:
Sentiment: Neutral
Publish Date: 2024-11-05 08:30:00
FREMONT, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today that it completed a secondary equity offering. On Friday November 1, the Company received approximately $96 million dollars net of fees related to the transaction. As a result, the Company now expects to close 2024 with cash levels of approximately $245 million, compared to the prior expectation of $150 million.
Sentiment: Negative
Publish Date: 2024-11-04 08:59:06
Enovix Co. NASDAQ: ENVX develops and manufactures next-generation silicon-anode lithium-ion batteries with applications in the smartphone, wearables, mobile device, VR/AR headset, laptop, IoT and electric vehicle (EV) markets. While the oils/energy sector company is producing batteries on a small scale now, it plans to ramp up mass production by the fourth quarter of 2025 at its new high-volume manufacturing Fab2 facility in Penang, Malaysia.
Sentiment: Positive
Publish Date: 2024-11-01 10:56:12
After losing some value lately, a hammer chart pattern has been formed for Enovix Corporation (ENVX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Sentiment: Positive
Publish Date: 2024-10-31 01:30:00
Advanced lithium-ion battery manufacturer Enovix reported Q3/2024 results in line with muted expectations. As the company continues to invest in its Malaysian manufacturing operations, cash burn remains elevated. While the company's financial performance was nothing to write home about, investors cheered the announcement of a new development agreement with a leading Chinese smartphone OEM. On the conference call, management reiterated expectations for high volume manufacturing to ramp in late 2025 and rising exponentially in 2026.
Sentiment: Positive
Publish Date: 2024-10-30 19:46:00
FREMONT, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (NASDAQ: ENVX), a global high-performance battery company, today announced the pricing of an underwritten public offering of 10,416,667 shares of its common stock for total gross proceeds of $100 million before deducting underwriting discounts and commissions and estimated offering expenses payable by Enovix. The offering is expected to close on November 1, 2024, subject to satisfaction of customary closing conditions. All of the shares of common stock in the offering will be sold by Enovix.
Sentiment: Positive
Publish Date: 2024-10-30 16:01:00
FREMONT, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (NASDAQ: ENVX), a global high-performance battery company, today announced that it has commenced an underwritten public offering of $100.0 million of shares of its common stock, subject to market and other conditions. In connection with the offering, Enovix expects to grant the underwriter a 30-day option to purchase up to an additional $15.0 million of the shares of common stock offered in the public offering. There can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares of common stock in the offering will be sold by Enovix.
Sentiment: Positive
Publish Date: 2024-10-29 22:48:07
Enovix Corporation (NASDAQ:ENVX ) Q3 2024 Earnings Conference Call October 29, 2024 5:00 PM ET Company Participants Robert Lahey - Head-Investor Relations Raj Talluri - President & Chief Executive Officer Farhan Ahmad - Chief Financial Officer Ajay Marathe - Chief Operating Officer Conference Call Participants Ananda Baruah - Loop Capital Markets Colin Rusch - Oppenheimer Bill Peterson - JPMorgan George Gianarikas - Canaccord Gus Richard - Northland Gabe Daoud - Cowen Derek Soderberg - Cantor Sean Milligan - Janney Mark Shooter - William Blair Tony Stoss - Craig-Hallum Operator Thank you for standing by, and welcome to the Enovix Corporation Third Quarter 2024 Earnings Conference Call. Currently, all participants are in a listen-only mode.
Sentiment: Negative
Publish Date: 2024-10-29 19:01:15
Enovix Corporation (ENVX) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.19 per share a year ago.
Sentiment: Positive
Publish Date: 2024-10-29 16:02:00
FREMONT, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today that it executed a development agreement with one of the leading global smartphone OEMs with top 5 market share in China. Under the terms of the agreement and subject to applicable milestones, the companies will develop a 100% active silicon anode battery customized for specific smartphone models targeted for launch in Q4 2025. The company now has agreements with 2 of the leading smartphone OEMs and has further sales momentum building in IoT and EV markets.
Sentiment: Neutral
Publish Date: 2024-10-28 08:42:27
Enovix Corp ENVX is revving up for its third-quarter earnings on Tuesday. With the stock up a whopping 60% in the past six months, the big question is, can it keep the momentum going?
Sentiment: Positive
Publish Date: 2024-10-25 10:56:13
The mean of analysts' price targets for Enovix Corporation (ENVX) points to a 104.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Sentiment: Positive
Publish Date: 2024-10-17 18:14:01
Enovix is a speculative pre-revenue company developing small batteries for wearable devices, with a price target of $17 by end of 2025. Recent shipment of EX-1M battery cell samples from Malaysia indicates progress towards high-volume production in 2025, a crucial milestone. Despite expected shareholder dilution, insider stock purchases show confidence; Enovix aims for 50% gross margins and 30% operating margins by 2026.
Sentiment: Neutral
Publish Date: 2024-10-17 14:25:24
Amid another week of earnings season volatility, there are two major market movers this afternoon, heading in opposite directions on the charts.
Sentiment: Neutral
Publish Date: 2024-10-16 19:56:00
FREMONT, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced it will release financial results for the third quarter of 2024 on Tuesday, October 29, 2024, after the close of the market.
Sentiment: Positive
Publish Date: 2024-10-14 07:46:09
Investors looking to minimize their day-to-day involvement in portfolio management—or to reduce their inclination to make impulsive trades—frequently turn to a buy-and-hold strategy. This approach to investing typically involves identifying target securities that are likely to provide solid returns over an extended period of time based on their fundamentals, adding them to a portfolio, and leaving them untouched even as share prices might experience local volatility.
Sentiment: Positive
Publish Date: 2024-10-05 09:14:37
Enovix is a pre-profit battery manufacturer trading 30% below its IPO price, focusing on higher energy density silicon-anode cells using their unique patented cell architecture. Wall Street estimates assume the company will achieve roughly 4.6% market share across their $12bn TAM in FY27. Financial forecasts suggest profitability by FY27, but high cash burn and potential dilution pose risks, justifying a 'hold' rating.
Sentiment: Positive
Publish Date: 2024-10-02 08:30:00
FREMONT, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today that it commenced shipping EX-1M battery cell samples from its new Agility Line in Malaysia last week. This is an important milestone on the Company's journey to scale which follows shipping initial samples from Fab1 in California, and opening high-volume Fab2 in Malaysia just this summer. Enovix also recently completed internal UN38.3 certification for cells now shipping. UN38.3 is the United Nations standard for safe transportation of Lithium-ion batteries and is only granted to products that meet strict international safety and abuse tolerance standards through a series certified test protocol. By shipping samples within the third quarter of 2024, the Company is on track to commence high-volume production in 2025.
Sentiment: Neutral
Publish Date: 2024-09-10 11:49:00
FREMONT, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced its participation in the following investor event:
Sentiment: Positive
Publish Date: 2024-09-02 08:44:27
Enovix has completed Site Acceptance Testing for its Fab-2 Agility line in Malaysia and started to produce the first batch of EX-1M samples, which has been sent to customers. The company secured a partnership with Elentec, signed an agreement with a leading California-based technology company and a Fortune 200 company. Enovix reports strong financials, with revenue meeting expectations and adjusted EBITDA loss improving, while continuing to invest in R&D for future growth.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
